Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
REPLICATE
Statement Of Use - To Examiner
Show more
Class 5: Pharmaceutical and biologic preparations for the treatment of inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response
Class 42: Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases
Class 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaS
Status timeline
- 9 Dec 2021Application filedNew Application Entered
- 14 Sep 2022Assigned to an examining attorneyAssigned To Examiner
- 26 Sep 2022Office action issuedNon-Final Action Written
- 12 Jan 2023Response to office action filedTeas Response To Office Action Received
- 10 Feb 2023Approved for publicationApproved For Pub - Principal Register
- 21 Mar 2023Published for oppositionPublished For Opposition
- 16 May 2023Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 20 May 2023Statement-of-use extension 1 grantedSou Extension 1 Granted
- 28 Mar 2024Statement-of-use extension 2 grantedSou Extension 2 Granted
- 23 Dec 2024Statement-of-use extension 3 grantedSou Extension 3 Granted
- 27 Apr 2026Statement of use filedTeas Statement Of Use Received
- 25 Aug 2026Assigned to an examining attorneyAssigned To Examiner
All 39 events
| 2026-08-25 | Assigned To Examiner |
| 2026-05-01 | Statement Of Use Processing Complete |
| 2026-04-27 | Teas Statement Of Use Received |
| 2026-04-27 | Use Amendment Filed |
| 2025-11-21 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-11-20 | Sou Extension 5 Granted |
| 2025-11-14 | Sou Teas Extension Received |
| 2025-11-13 | Sou Extension 5 Filed |
| 2025-05-16 | Sou Extension 4 Granted |
| 2025-05-16 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-05-15 | Sou Teas Extension Received |
| 2025-05-15 | Sou Extension 4 Filed |
| 2024-12-23 | Sou Extension 3 Granted |
| 2024-12-23 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-12-20 | Case Assigned To Intent To Use Paralegal |
| 2024-11-12 | Sou Teas Extension Received |
| 2024-11-12 | Sou Extension 3 Filed |
| 2024-03-29 | Notice Of Approval Of Extension Request E-Mailed |
| 2024-03-28 | Sou Teas Extension Received |
| 2024-03-28 | Sou Extension 2 Filed |
| 2024-03-28 | Sou Extension 2 Granted |
| 2023-05-23 | Notice Of Approval Of Extension Request E-Mailed |
| 2023-05-20 | Sou Teas Extension Received |
| 2023-05-20 | Sou Extension 1 Filed |
| 2023-05-20 | Sou Extension 1 Granted |
| 2023-05-16 | Noa Mailed - Sou Required From Applicant |
| 2023-03-21 | Published For Opposition |
| 2023-03-21 | Official Gazette Publication Confirmation E-Mailed |
| 2023-03-01 | Notification Of Notice Of Publication E-Mailed |
| 2023-02-10 | Approved For Pub - Principal Register |
| 2023-01-13 | Teas/Email Correspondence Entered |
| 2023-01-12 | Teas Response To Office Action Received |
| 2023-01-12 | Correspondence Received In Law Office |
| 2022-09-26 | Non-Final Action Written |
| 2022-09-26 | Non-Final Action E-Mailed |
| 2022-09-26 | Notification Of Non-Final Action E-Mailed |
| 2022-09-14 | Assigned To Examiner |
| 2021-12-10 | New Application Office Supplied Data Entered |
| 2021-12-09 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceutical and biologic preparations for the treatment of inflammatory disorders and diseases, and infectious disorders and diseases; Biological compounds being a component in vaccines; Therapeutic agents and immunotherapies for the treatment of inflammatory diseases, and infectious diseases; Biological compound for medical use, namely, self-replicating RNAs delivered into patient cells for creating therapeutic proteins; Therapeutic agents for generating or evading protective immune response
First use anywhere 0 Apr 2023 · First use in commerce 0 Aug 2023
Class 42 Technology & SaaS
Research and development services in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases; Providing medical scientific information in the fields of self-replicating RNAs, RNA therapeutics, pharmaceuticals, biologics, therapeutic proteins, inflammatory diseases, and infectious diseases
First use anywhere 0 Nov 2025 · First use in commerce 0 Nov 2025
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 25 Aug 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.